Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 5646-5648, December 15, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Janssens, M. Y.
Right arrow Articles by Storme, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Janssens, M. Y.
Right arrow Articles by Storme, G. A.

Activation of Inducible Nitric Oxide Synthase Results in Nitric Oxide-mediated Radiosensitization of Hypoxic EMT-6 Tumor Cells1

Marleen Y. Janssens2, Dirk L. Van den Berge, Valeri N. Verovski, Christinne Monsaert and Guy A. Storme

Cancer Research Unit, Department of Radiotherapy, Oncology Center, Academic Hospital, Free University Brussels, 1090 Brussels, Belgium

EMT-6 cells treated for 16 h with 1–10 units/ml IFN-{gamma} showed a gradual activation of inducible nitric oxide synthase (iNOS) in Western and Northern blots, a simultaneous raise in NO output, and an increase in hypoxic cell radiosensitivity almost to the level of aerobic cells. Both the NO signal and radiosensitization were counteracted by the NO scavenger oxyhemoglobin, by the specific iNOS inhibitor aminoguanidine, and by the L-arginine analogue NG-monomethyl-L-arginine. Collectively, these data demonstrate that IFN-{gamma} can radiosensitize EMT-6 cells through iNOS induction and that NO is the effector molecular responsible for radiosensitization. Compared with the spontaneous NO releaser (2)-1-[N-(3-ammoniopropyl)-N-(n-propyl)amino)diazen-1-ium-1,2-diolate], the iNOS-generated NO signal appeared to be 10 times lower yet resulting in the same enhancement ratio of 2.4. Direct stimulation of NO synthesis in tumor cells through the L-arginine/iNOS pathway represents a novel approach to exploit the radiosensitizing properties of NO.

1 This research was funded by Grants G.0055.96 and G.0195.98 from the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen and Sportvereniging tegen Kanker and Vlaamse Kankerliga.

2 To whom requests for reprints should be addressed, at Department of Radiotherapy, Oncology Center, A.Z.-V.U.B., Laarbeeklaan 101, 1090 Brussels, Belgium. Phone: 32-2-4774534; Fax: 32-2-4776212; E-mail: dvdb@vub.vub.ac.be.

Received 9/11/98. Accepted 10/28/98.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. K. Leach, S. M. Black, R. K. Schmidt-Ullrich, and R. B. Mikkelsen
Activation of Constitutive Nitric-oxide Synthase Activity Is an Early Signaling Event Induced by Ionizing Radiation
J. Biol. Chem., May 3, 2002; 277(18): 15400 - 15406.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
Y.-Z. Wu, J.-H. Hong, H.-H. Huang, G. J. Dougherty, W. H. McBride, and C.-S. Chiang
Mechanisms mediating the effects of IL-3 gene expression on tumor growth
J. Leukoc. Biol., December 1, 2000; 68(6): 890 - 896.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.